These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7526277

  • 1. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
    [Abstract] [Full Text] [Related]

  • 2. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 3. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P, Pouteau M, Loriot MA, Boyer N, Degos F, Calès P, Bettan L, Bacq Y, Coppére H, Grange JD.
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [Abstract] [Full Text] [Related]

  • 4. [Preliminary clinic observation on the inhibition of HBV by receptor-targeted drug L-HSA-AraAMP].
    Wang H, Zhang L, Wang X.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):12-4. PubMed ID: 12515162
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract] [Full Text] [Related]

  • 6. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH.
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A, Debernardi-Venon W, Smedile A, Brunetto MR, Torrani Cerenzia MR, Actis GC, Zamboni F, Ghisetti V, Piantino P, David E, Salizzoni M, Rizzetto M.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
    [Abstract] [Full Text] [Related]

  • 10. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
    Torrani Cerenzia M, Fiume L, De Bernardi Venon W, Lavezzo B, Brunetto MR, Ponzetto A, Di Stefano G, Busi C, Mattioli A, Gervasi GB, Bonino F, Verme G.
    Hepatology; 1996 Apr; 23(4):657-61. PubMed ID: 8666314
    [Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV.
    J Hepatol; 1986 Apr; 3 Suppl 2():S107-10. PubMed ID: 2439568
    [Abstract] [Full Text] [Related]

  • 12. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA.
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [Abstract] [Full Text] [Related]

  • 13. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA, Buffello-Le Guillou D, Roche B, Dussaix E, Duclos-Vallée JC, Féray C, Samuel D.
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [Abstract] [Full Text] [Related]

  • 16. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
    Ouzan D, Degos F, Marcellin P, Linberg J, Chevallier M, Degott C, Bréchot C, Chossegros P, Weiss AM, Hirtz J.
    Gastroenterol Clin Biol; 1987 Nov; 11(8-9):568-73. PubMed ID: 3308617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z, Jelev D, Antonov K, Alagozian V, Kotzev I.
    Hepatogastroenterology; 1999 Nov; 46(30):3184-8. PubMed ID: 10626183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.